Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Evaluate the population-level effects of OPSs and SCSs on acute health service use and mortality.

Original research | 2022
Overdose, Mortality, Evidence base, SCS/OPS, Outcomes, Hospitals

We report on a cost analysis study, using population level data to determine the emergency service costs avoided from emergency overdose management at supervised consumption services (SCS).

Original research | 2022
Overdose, Evidence base, SCS/OPS, Harm reduction

The aim of our study was to explore points of view of people who use drugs (PWUD) treated with Opioid Medication Therapies (methadone and buprenorphine), in a large multicentre sample.

Original research | 2022
Substitution/OAT, About PWUD
Webpage | 2022
Harm reduction
Webpage | 2022
Harm reduction

To gain a nuanced understanding of provider perspectives on MOUD care delivery using telemedicine, we conducted semi-structured interviews with VHA providers who were using telehealth to deliver MO

Original research | 2022
About prescribers, Digital health

Given the racist evolution of the war on drugs and the harm reduction (HR) movement, the aim of this study is to explore racism within harm reduction services through the perspectives of our partic

Original research | 2022
About PWUD, Harm reduction, Equity, Legal system/law enforcement
Report | 2021
About PWUD, Policy/Regulatory, Advocacy, Equity

In the context of an overdose crisis linked to fentanyl, we used drug checking data to examine variability within the illicit opioid supply.

Original research | 2022
Overdose, Evidence base, Drug checking, Illegal drugs
Report | 2022
Safer supply, Evidence base, Policy/Regulatory, Outcomes
Page Web | 2022
l'approvisionnement plus sécuritaire, la politique / le cadre de réglementation, la base de donnés probantes, les résultats

This is a summary of an independent assessment report prepared by Dale McMurchy Consulting based on information gathered through surveys and interviews with safer supply program leads, staff and pa

Webpage | 2022
Safer supply, Policy/Regulatory, Evidence base, Outcomes

This research assessed the impact of COVID-19 on staff working at harm reduction and alcohol and other drug (AOD) services in Australia in the first 9 months of the pandemic.

Original research | 2022
Wrap-around services, Harm reduction

Given the continued expansion of community pharmacy in the continuum of care, it is imperative to characterize alcohol use among pharmacy patients dispensed opioids in order to establish a foundati

Original research | 2022
About pharmacists
Webpage | 2022
Policy/Regulatory, Safer supply
Guidelines | 2018
SCS/OPS, Clinical guidance, Harm reduction, Social services, Illegal drugs

This Evidence Brief asks: What is the evidence of effectiveness of supervised injectable opioid agonist treatment with diacetylmorphine (DAM) or hydromorphone (HDM) on treatment retention (i.e., in

Report | 2017
Evidence base, Safer supply
Report | 2019
Policy/Regulatory, Advocacy, Illegal drugs, Crime

Affiner votre recherche

Mots clés
Format
Région